News:

This week IPhone 15 Pro winner is karn
You can be too a winner! Become the top poster of the week and win valuable prizes.  More details are You are not allowed to view links. Register or Login 

Main Menu

Insight: Big Pharma braces for retirement of favorite regulator

Started by riky, October 11, 2013, 09:00:19 AM

Previous topic - Next topic

0 Members and 2 Guests are viewing this topic.

riky

Insight: Big Pharma braces for retirement of favorite regulator

<p><a href="http://news.yahoo.com/insight-big-pharma-braces-retirement-favorite-regulator-050603145.html"><img src="http://l1.yimg.com/bt/api/res/1.2/kFeYP_KfO43vbZZ2po1Ocw--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9NzU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-10-10T050603Z_1_CBRE9990E6T00_RTROPTP_2_HEALTH-SUMMIT.JPG" width="130" height="86" alt="Woodcock, Director of the Center for Drug Evaluation and Research at FDA, speaks during the Reuters Health Summit in New York" align="left" title="Woodcock, Director of the Center for Drug Evaluation and Research at FDA, speaks during the Reuters Health Summit in New York" border="0" /></a>By Toni Clarke WASHINGTON (Reuters) - The retirement of Dr. Janet Woodcock as head of the Food and Drug Administration's pharmaceutical division is at least a year away, but already the industry she regulates is worrying about who will replace her. Over the past 20 years Woodcock, who is 65, has reshaped the drug approval process, relaxing the criteria needed for certain drugs to reach the market - especially those that represent scientific breakthroughs. Last year, the agency approved 39 new drugs, the most since 1996. ...</p><br clear="all"/>

Source: You are not allowed to view links. Register or Login
You are not allowed to view links. Register or Login